The high court won't hear a petition by Arthrex seeking to unwind the rejection of its patent claims by an acting director of the U.S. Patent Office.

Arthrex today announced it has served a patent infringement lawsuit against Smith & Nephew and its wholly-owned subsidiary, ArthroCare, Corp in th ...

Medical device company Arthrex Inc has agreed to pay $16 million to settle claims that it paid a Colorado orthopedic surgeon millions of dollars in kickbacks to use and recommend its products, the ...

Southwest Florida-based medical manufacturer Arthrex recently won a prestigious Edison Award for designing a new device that may transform bunion surgery. One in three people in the U.S. have one ...

The jury in Portland, Oregon, found that Arthrex’s Bio-SutureTak, Peek SutureTak, PushLock and Bio-PushLock violated the patent rights, London-based Smith & Nephew said in a statement today.

When Collier County Commission Chairwoman Penny Taylor heard of Arthrex's plans to expand in South Carolina, she wasn't surprised. She was disappointed. On Monday the company announced it would ...

The Petitions of the Week column highlights a selection of cert petitions recently filed in the Supreme Court. A list of all petitions we’re watching is available here. Two years ago, the court ruled ...

In 2004, Smith & Nephew sued Arthrex and alleged that certain products of Arthrex’s SutureTak® and PushLock® suture anchor families infringed the ‘557 patent (case number 3-04-cv-00029).

As most of us know by now, in Arthrex, Inc. v. Smith & Nephew, Inc., entered on Halloween 2019, a panel of the Federal Circuit held that the administrative patent judges (APJs) of the Patent Trial ...

The Federal Circuit and the patent world continues to grapple with the court’s decision in Arthrex v. Smith & Nephew. Since our last updates, the ...

Courtesy Photo Arthrex, an orthopedic surgical equipment manufacturer with a base in Santa Barbara, has been the latest to join the ranks of Fortune magazine’s “100 Best Companies to Work For.” Ranked ...

Arthrex has sued Parcus for patent infringement and capitalizing on trade secrets. Parcus has filed answers denying the allegations and a counterclaim against Arthrex.